Investing Profile

Bernard Davitian

InvestorVC

Partner at Omega Funds

Your Intro Paths to Bernard Davitian

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Bernard Davitian on

Current Investing Position

Investment Range

$100K - $5.0M

Sweet Spot

$1.5M

Investments On Record

Bernard Davitian is on these Sector & Stage Rankings

Bernard Davitian's Investments On Record (9)

Company	StageDateRound Size	Total Raised
Aviceda Therapeutics	Series CJan 2025$210M	$210M
Co-investors: Sara Nayeem (Avoro Ventures)
Endeavor BioMedicines	Series CApr 2024$130M Series BFeb 2022$100M Series AJan 2021$62M	$300M
Eyebiotech	Series ANov 2023$65M	$130M
Co-investors: Mike Ross (SV Health Investors), Kate Bingham (SV Health Investors)
Vanqua Bio	Series BSep 2021$85M	$85M
Co-investors: Stephen Squinto (OrbiMed), Jonathan Silverstein (OrbiMed), Mona Ashiya (OrbiMed Advisors), Sara Nayeem (Avoro Ventures)
LEXEO Therapeutics	Series BSep 2021$100M Series AJan 2021$85M	$190M
Click Therapeutics	Series AOct 2018$19M	$71M
Co-investors: Cris De Luca (Sanofi Ventures)
Evidation Health	Series UnknownApr 2017$10M	$110M
Co-investors: Raj Ganguly (B Capital Group), Adam Seabrook (B Capital Group), Michael Balmuth (SV Health Investors), Mike Pellini (Section 32), Skip Fleshman (Asset Management Ventures)
Lysosomal Therapeutics	Series AFeb 2015$20M SeedMay 2014$5M	$25M
Co-investors: Bruce Booth (Atlas Venture), Clay Thorp (Hatteras Venture Partners), Carole Nuechterlein (F.Hoffmann-La Roche)